{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-23-000016","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.248281+00:00","generated_at":"2026-06-20T03:05:58.663291+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeVantage Q2 revenue $53.7M (+2.8% YoY); net loss $0.08 EPS; guides FY rev $202-212M","bullets":["Revenue $53.7M, up 2.8% YoY (7.4% constant currency); Americas up 14.4%, Asia/Pac & Europe down 20.2%.","Net loss $1.1M ($0.08 per diluted share) vs net income $0.01 per share a year ago.","Adjusted EBITDA $0.8M vs $1.9M prior year; active accounts fell 8.6% to 149,000.","Declares $0.03 per share cash dividend, payable March 15, 2023 to holders of record March 1.","FY2023 guidance: revenue $202-212M, adj. EBITDA $11-13M, adj. EPS $0.22-0.28."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-23-000016","json":"https://secwatch.observer/filing/0000849146-23-000016.json","markdown":"https://secwatch.observer/filing/0000849146-23-000016.md","text":"https://secwatch.observer/filing/0000849146-23-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914623000016/0000849146-23-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914623000016/lfvn-20230202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T03:05:58.663291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b2d4bb18e12f57f112f6ac7004272efbb99ccbcf","claim":"Lifevantage Corp reported three and six months ended December 31, 2022 results: revenue $53.7 million. Guidance reaffirmed.","evidence_excerpt":"LifeVantage Corporation (Nas daq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2022. Second Quarter Fiscal 2023 Summary*: • Revenue of $53.7 million, an increase of 2.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was up approximately 7.4%; • Revenue in","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849146/000084914623000016/0000849146-23-000016-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and six months ended December 31, 2022"},{"label":"Revenue","value":"$53.7 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}